Medical Writing Visual Communications Planting a “non-biological” seed – will this meme persist?

Volume 29, Issue 1 - Visual Communications

Planting a “non-biological” seed – will this meme persist?


Some word uses persist and some do not. Part of what makes use of a word stick is how catchy it is. This word is already used on our supermarket shelves. This proposed new use illuminates a small way in which language evolves. And it helps to compartmentalise differences between chemical and biological manufacture of pharmaceuticals. The question is, will this word use persist enough to enter common vocabulary? The word is nonbiological.

Download the full article


  1. Darwin Correspondence Project, “Letter no. 5140,” [cited 2019 Oct 17]. Available from: letter/ DCP-LETT-5145.xml# mark- 5145.f3.
  2. Survival of the fittest. Wikipedia [cited 2019 Oct 17]. Available from: of_the_fittest.
  3. Dawkins R. The Selfish Gene. Oxford: Oxford University Press; 1976.
  4. Cavalli-Sforza LL. Genes, Peoples and Languages. Allen Lane: The Penguin Press; 2000.
  5. Internet meme. Wikipedia [cited 2020 Jan 01]. Available from: meme.
  6. French C. Personal communication at The University of Edinburgh. 2004.
  7. The IBN SINA Pharmaceutical Industry Ltd. Bactin® (ciprofloxacin USP) [cited 2019 Oct 20]. Available from: /pharma/general/by-brandname/ detail/bactin/.
  8. Walsh G. Bio-pharmaceutical Benchmarks. Nat. Biotechnol. 2018;36(12):1136–45
  9. The Motley Fool. What Is a Small-Molecule Drug? 2016 [cited 2020 Jan 01]. Available from: what-is-a-small-molecule-drug.aspx.
  10. Thierauch K-H. Small Molecule Drugs. In: Schwab M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg; 2011.
  11. Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074–82.
  12. US FDA. Non-Biological Complex Drugs – Challenges for approval standards and opportunities!! [cited 2020 Jan 01]. Available from: media/125176/download.
  13. Hussaarts L, Műhlebach S, Shah VP, et al. Equivalence of complex drug products: advances in and challenges for current regulatory frameworks, Ann. N. Y. Acad. Sci. 2017;1407: 39–49.
  14. Karshikoff A, Nilsson L, Ladenstein R. Rigidity versus flexibility: the dilemma of understanding protein thermal stability. FEBS J. 2015;282(20):3899–917.
  15. Rader R, Langer E. Top trends in the biopharmaceutical Industry and bioprocessing for 2019, 2018 [cited 2020 Jan 01]. Available from: top-trends-in-the-biopharmaceuticalindustry- and-bioprocessing-for-0001.
  16. Radovan D. Biosimilar development – an overview. MEW. 2019;28(2):20–7.
  17. European Medical Writers Association. Generics and biosimilars. Med Writ. 2019;28(2).
  18. Thambavita D, Galappatthy P, Jayakody RL. Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities. J Pharm Policy and Pract. 2018;11:14;1–8.
  19. Benet LZ. The role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in drug development. J Pharm Sci. 2013;102(1);34–42.
  20. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3);413–20.
  21. Crommelin DJA, de Vlieger JSB, Weinstein V, Műhlebach S, Shah VP, Schellekens H. Different pharmaceutical products need similar terminology. AAPS J. 2014;16(1);11–4.
  22. Geigert J. Biologics are not chemical drugs. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics, 3rd ed. Springer New York; 2019;33–51.



President's Message
Medical illustration in the 21st century and beyond
Visualisations in science communication: Friend or foe?
How and why it works: The principles and history behind visual communication
Get your (visual) act together: Optimising the design of labels and arrows in medical illustrations
A picture is worth a thousand words
The evolution of the scientific poster: From eye-sore to eye-catcher
Leveraging infographics in study schemas
Enhancing accessibility of study data: The development of a graphical abstract for lay summaries of clinical trial results
Connecting medical writers in Portugal through visual communication
Clinical trial design: Considerations for medical writers developing clinical trial protocols
Planting a “non-biological” seed – will this meme persist?
Regulatory Matters
News from the EMA
Journal Watch
Getting Your Foot in the Door
Veterinary Medical Writing
Good Writing Practice
Medical Writing Humour
Out on our Own

Member Login


The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board



Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: